Dergiler / Üroonkoloji Bülteni / 2018 / Cilt: 17 - Sayı: 1

İntravezikal Bacillus Calmette-Guérin Tedavisinin Nadir Görülen Yan Etkisi: Reaktif Artrit

A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis

Bahattin KIZILGÖK,VOLKAN İZOL,Eren ERKEN,Mustafa Zühtü TANSUĞ

Sayfa
79–82
DOI
—

Özet

1Çukurova Üniversitesi Tıp Fakültesi, Üroloji Anabilim Dalı, Adana, Türkiye2Çukurova Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Romatoloji Bilim Dalı, Adana, TürkiyeDr. Bahattin Kızılgök1, Dr. Volkan İzol1, Dr. Eren Erken2, Dr. Mustafa Zühtü Tansuğ1İntravezikal Bacillus Calmette-Guérin Tedavisinin Nadir Görülen Yan Etkisi: Reaktif ArtritA Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritisklinik vermektedir (10,11). Biz bu olgu sunumumuzda kasa invaziv olmayan mesane kanseri nedeniyle TUR-M yapılan ve sonrasında intravezikal BCG tedavisi uygulanırken reaktif artrit gelişen olgumuzu sunduk.Olgu Sunumu

Abstract

Approximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour (TUR-BT) is the standard approach to these patients. Intravesical treatments such as adriamycin, doxorubicin, epirubicin, mitomycin-c and bacillus Calmette-Guérin (BCG) may be performed after TUR-BT in order to prevent further recurrence or progression. BCG is generally used in high-risk patients and causes local or systemic side effects in less than 5% of patients. Osteoarticular side effects are very rare and usually manifest as joint pain and arthritis . In this case report, we present the management of reactive arthritis in a patient treated with intravesical BCG for bladder cancer